Selective Precision Targeting (SPoT)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Center for Advancing Translational Science (NCATS) is initiating a program called Selective Precision Targeting (SPoT) aimed at developing precise mechanisms for therapeutic drug delivery to difficult-to-access areas within the human body. This initiative focuses on utilizing microphysiological systems (MPS) to enhance targeted drug delivery methods such as engineered nanoparticles, extracellular vesicles, and focused ultrasound, with an emphasis on reaching locations like the blood–brain barrier, central nervous system, placenta, retina, or tumors. The program intends to optimize targeting accuracy, evaluate drug distribution and off-target effects using multi-organ MPS models, demonstrate the functional activity of delivered therapeutic cargo, and identify the best routes of administration. This opportunity, governed under the authority of the Cures Acceleration Network, seeks to advance innovative strategies to increase drug concentration at the disease site while minimizing systemic exposure. The project is under the auspices of the Department of Health and Human Services, specifically through the National Institutes of Health, with a point of contact at NCATS available for further information. The SPoT initiative represents a significant step toward improving precision medicine by enabling the delivery of therapeutics to challenging anatomical targets using sophisticated model systems.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Center for Advancing Translational Science (NCATS) seeks to advance its mission by establishing a new initiative called Selective Precision Targeting (SPoT) to determine a mechanism for precise and on-target therapeutic drug delivery to specific hard-to-reach locations within the human body using microphysiological systems (MPS). Targeted drug-delivery systems, including engineered nanoparticles, extracellular vesicles or focused ultrasound, are methods for delivering medications to a specific area of the body (organ, tissue, or cell) to increase the concentration of the drug in that area. Hard-to-reach locations in the body include the blood–brain barrier, central nervous system, placenta, retina, or a tumor.
More specifically, the initiative goals are to:
- Optimize specific targeting of nanoparticle therapeutics to the target organ/cell of interest
- Assess biodistribution and off-target effects using a multi-organ microphysiological system
- Provide evidence of functional cargo activity
- Determine optimal route of administration
Grant authorities that allow the National Center for Advancing Translational Science (NCATS) to forecast this opportunity are as follows: 42 U.S. Code § 287a - Cures Acceleration Network.
